|
| |
| | 62131 | | 05.03.2012 | | Pfizer AG | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Xalkori 200 mg | Hartkapseln | Capsules (Crizotinibum 200 mg) | L01ED01 | CI | 02 | Xalkori 250 mg | Hartkapseln | Capsules (Crizotinibum 250 mg) | L01ED01 | CI |
|
|
|